| Stereochemistry | RACEMIC |
| Molecular Formula | C21H23ClN2O2 |
| Molecular Weight | 370.873 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C(OC)C(Cl)=C(CC2NCCC3=C2NC4=C3C=C(C)C=C4)C=C1
InChI
InChIKey=NJLHHCITDFZZSE-UHFFFAOYSA-N
InChI=1S/C21H23ClN2O2/c1-12-4-6-16-15(10-12)14-8-9-23-17(20(14)24-16)11-13-5-7-18(25-2)21(26-3)19(13)22/h4-7,10,17,23-24H,8-9,11H2,1-3H3
| Molecular Formula | C21H23ClN2O2 |
| Molecular Weight | 370.873 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 19.5 nM [Ki] | |||
| 24.55 nM [Ki] |
